Battle against Preeclampsia: Where Do We Stand Today?
Rebecca Khan, MD, FACOG
Lab-developed, FDA-cleared assays that use validated biomarkers could help detect and manage preeclampsia
The model analyzes methylation changes in the cell-free DNA of pregnant women at risk of preeclampsia
Women with a high DNA methylation score would be prone to HPV infection, AIS, and ADC
Accessible screening tests and inclusive management strategies could reduce cervical cancer globally
Multicenter clinical trials demonstrated the efficacy of Zurzuvae in women with PPD
Women’s health demands attention and intervention—more than ever before—to better understand the impact of various stressors